How should I manage an otherwise healthy adult hypothyroid patient presenting with shivering (cold intolerance), including initial levothyroxine dosing and follow‑up?

Management of Hypothyroidism with Shivering (Cold Intolerance)

Immediate Treatment Recommendation

Start levothyroxine immediately at an age- and cardiac-appropriate dose to address the metabolic slowing causing cold intolerance and other hypothyroid symptoms. 1, 2, 3

---

Initial Diagnostic Confirmation

Before initiating therapy, confirm the diagnosis biochemically:

• Measure TSH and free T4 to distinguish overt hypothyroidism (high TSH, low free T4) from subclinical hypothyroidism (high TSH, normal free T4). 1, 4
• Cold intolerance is a cardinal symptom of hypothyroidism, occurring alongside fatigue (68-83%), weight gain (24-59%), and cognitive issues (45-48%). 4, 5
• If TSH is elevated on initial testing, repeat TSH and free T4 after 3-6 weeks to confirm persistence, as 30-60% of elevated TSH values normalize spontaneously. 1, 6

---

Critical Safety Assessment Before Starting Levothyroxine

Rule out concurrent adrenal insufficiency before initiating levothyroxine, especially if central hypothyroidism or hypophysitis is suspected, as starting thyroid hormone before corticosteroids can precipitate life-threatening adrenal crisis. 7, 1, 2

• Obtain morning (≈8 AM) cortisol and ACTH levels if the patient has hypotension, hyponatremia, unexplained symptoms, or suspected pituitary disease. 7, 1
• If adrenal insufficiency is present, start hydrocortisone 20 mg in the morning and 10 mg in the afternoon for at least one week before levothyroxine. 7, 1

---

Initial Levothyroxine Dosing Strategy

For Otherwise Healthy Adults <70 Years Without Cardiac Disease

Start levothyroxine at full replacement dose of 1.6 mcg/kg/day (typically 100-125 mcg daily for most adults). 1, 2, 3

• This approach rapidly normalizes thyroid function and relieves symptoms including cold intolerance. 1, 3
• The full replacement dose is appropriate for younger patients without cardiac risk factors. 1, 3

For Patients >70 Years or With Cardiac Disease/Atrial Fibrillation

Start at a lower dose of 25-50 mcg/day to avoid unmasking cardiac ischemia or precipitating arrhythmias. 1, 2, 3, 5

• Elderly patients and those with coronary artery disease are at increased risk of cardiac decompensation even with therapeutic levothyroxine doses. 1, 6, 5
• Titrate more slowly in these patients, increasing by 12.5-25 mcg every 6-8 weeks based on TSH response. 1, 2, 3

---

Administration Instructions

• Take levothyroxine as a single daily dose on an empty stomach, 30-60 minutes before breakfast with a full glass of water. 3, 5
• Administer at least 4 hours before or after iron, calcium supplements, or antacids, which interfere with absorption. 3, 8
• Avoid taking with soybean-based foods, which decrease absorption. 3

---

Monitoring and Dose Titration

Initial Monitoring Phase

Recheck TSH and free T4 at 6-8 weeks after starting levothyroxine or after any dose change, as this represents the time needed to reach steady state. 1, 2, 3, 4

• Adjust dose by 12.5-25 mcg increments based on TSH results until the patient is clinically euthyroid. 1, 2, 3
• Target TSH within the reference range of 0.5-4.5 mIU/L with normal free T4 levels. 1, 2
• Free T4 helps interpret ongoing abnormal TSH levels during therapy, as TSH may take longer to normalize. 1

Long-Term Monitoring

Once TSH is stable at goal, monitor TSH every 6-12 months or sooner if symptoms change. 1, 2, 4, 5

• Annual monitoring is sufficient for stable patients on a consistent dose. 2, 9

---

Expected Symptom Resolution Timeline

• Cold intolerance and other hypothyroid symptoms should improve within 6-8 weeks of adequate levothyroxine replacement. 1, 4
• The peak therapeutic effect of a given levothyroxine dose may not be attained for 4-6 weeks. 3
• If symptoms persist despite normalized TSH, reassess for other causes or consider referral. 5

---

Common Pitfalls to Avoid

Overtreatment Risks

Approximately 25% of patients on levothyroxine are unintentionally maintained on doses sufficient to fully suppress TSH, increasing risks for atrial fibrillation, osteoporosis, fractures, and cardiovascular mortality. 1, 4

• If TSH falls below 0.1 mIU/L, reduce levothyroxine by 25-50 mcg immediately. 1, 2
• For TSH 0.1-0.45 mIU/L, decrease by 12.5-25 mcg, especially in elderly or cardiac patients. 1, 2

Undertreatment Risks

Persistent hypothyroid symptoms, adverse cardiovascular effects, abnormal lipid metabolism, and reduced quality of life result from inadequate replacement. 1, 4

Premature Dose Adjustment

Do not adjust levothyroxine dose before 6-8 weeks, as steady state has not been reached and premature changes lead to inappropriate dosing. 1, 2, 3

Treating Based on Single Abnormal TSH

Do not treat based on a single elevated TSH value without confirmation, as 30-60% normalize spontaneously and may represent transient thyroiditis. 1, 6

---

Special Considerations

Pregnancy

Women with hypothyroidism who become pregnant should increase their weekly levothyroxine dosage by 30% (take one extra dose twice per week), followed by monthly TSH monitoring. 5

Patients on Immune Checkpoint Inhibitors

Thyroid dysfunction occurs in 6-20% of patients on anti-PD-1/PD-L1 therapy. 7, 1

• Consider treatment even for subclinical hypothyroidism if fatigue or cold intolerance is present. 7, 1
• Continue immunotherapy in most cases, as thyroid dysfunction rarely requires treatment interruption. 7, 1

Subclinical Hypothyroidism (TSH >10 mIU/L with Normal Free T4)

Initiate levothyroxine regardless of symptoms when TSH persistently exceeds 10 mIU/L, as this carries approximately 5% annual risk of progression to overt hypothyroidism. 1, 4, 6